|
Jan 3
|
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Jan 3
|
Xencor (XNCR) Soars 6.0%: Is Further Upside Left in the Stock?
|
|
Dec 30
|
Insider Sell: Xencor Inc President & CEO Bassil Dahiyat Sells 45,000 Shares
|
|
Dec 10
|
Xencor (NASDAQ:XNCR) shareholders are up 7.7% this past week, but still in the red over the last three years
|
|
Nov 7
|
Xencor Reports Third Quarter 2023 Financial Results
|
|
Nov 7
|
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million
|
|
Nov 3
|
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
|
|
Aug 8
|
Analysts Just Published A Bright New Outlook For Xencor, Inc.'s (NASDAQ:XNCR)
|
|
Aug 7
|
Xencor, Inc. (NASDAQ:XNCR) Q2 2023 Earnings Call Transcript
|